Coeptis Therapeutics Holdings, Inc.
COEP
$15.92
-$0.04-0.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 237.40K | 200.70K | 62.90K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 237.40K | 200.70K | 62.90K | -- | -- |
| Cost of Revenue | 45.20K | 45.20K | 45.20K | -- | -- |
| Gross Profit | 192.30K | 155.50K | 17.70K | -- | -- |
| SG&A Expenses | 1.83M | 4.14M | 3.74M | 1.57M | 1.08M |
| Depreciation & Amortization | 250.00K | 250.00K | 250.00K | 250.00K | 250.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.71M | 4.72M | 4.12M | 2.16M | 2.14M |
| Operating Income | -2.48M | -4.52M | -4.06M | -2.16M | -2.14M |
| Income Before Tax | -2.90M | -4.33M | -3.42M | -3.01M | -1.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.90M | -4.33M | -3.42M | -3.01M | -1.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 159.40K | -207.40K | 363.20K | 1.06M | 96.30K |
| Net Income | -2.74M | -4.54M | -3.06M | -1.95M | -1.73M |
| EBIT | -2.48M | -4.52M | -4.06M | -2.16M | -2.14M |
| EBITDA | -2.18M | -4.23M | -3.76M | -1.91M | -1.89M |
| EPS Basic | -0.58 | -1.22 | -1.00 | -0.95 | -0.04 |
| Normalized Basic EPS | -0.27 | -0.85 | -0.58 | -0.34 | -0.03 |
| EPS Diluted | -0.58 | -1.22 | -1.00 | -0.95 | -0.04 |
| Normalized Diluted EPS | -0.27 | -0.85 | -0.58 | -0.34 | -0.03 |
| Average Basic Shares Outstanding | 4.75M | 3.73M | 3.07M | 2.05M | 39.81M |
| Average Diluted Shares Outstanding | 4.75M | 3.73M | 3.07M | 2.05M | 39.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |